Loading...

1,830 posters, 67 videos, 75 audios, 29 topics, 22 sessions, 4,727 authors, 1,697 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2023

June 12 - 14, 2023 | London, UK

RCOG World Congress 2023 banner

EP.0190

Gestational Diabetes: Diet or Medication?

Part of Topic

High Risk Pregnancy

Submission ID
1653
Title 
Gestational Diabetes: Diet or Medication?
 

Objective: To study the effect of diet control in women with Gestational Diabetes Mellitus (GDM) on pregnancy and pregnancy outcomes, and the need for glucose control medication, in a single Emirati hospital. 

Design: Hospital based retrospective descriptive study 

Method: Data were collected manually from electronic medical records in the period 1-10-2020 to 31-3-2021. All women who delivered in our hospital in the study period, and were diagnosed with GDM were included. The study group was classified into 4 categories: GDM controlled with diet only, GDM controlled with diet and needed medication, GDM not on diet and needed no medication, and GDM not on diet but needed medication. Medication to control blood sugar is either metformin, insulin, or both. Study variables were; need for medication, duration of pregnancy, induction of labour (IOL), polyhydramnios, shoulder dystocia, and fetal weight on delivery. Demographic characteristics of the study group was described. Data were entered in Excel sheets and described in numbers and percentages. 

Results: 138 cases of GDM patients were identified, most aged 21-40 years (N=118, 85.5%), about half were Emirati Nationals (N=74, 53.6%), most were parous (N=122, 88.4%), and least primigravidae (N=16, 11.6%). Of the 138 cases, 121 patients followed dietary advice (87.7%), out of those more than half did not need medication (N=66, 54.5%), while 55 needed medication (45.5%). 17 patients (12.3%) did not follow diet advice, and most of these needed medication (N=13, 76.5%). Of the 66 who were on diet only, 54 were overweight to morbid obese (81.8%). Of the 55 who needed medication with the diet, 48 were overweight to morbid obese (87.3%). 27 pregnancies continued to 40-41 week (19.6%), most of them in the diet only group (N=18, 85.7%). 2 patients (1.4%) had polyhydramnios, 1 in the diet only, and 1 in the no diet with medication group, only 2 (1.4%) had shoulder dystocia, both in the diet with medication group. 79 patients (57.2%) had induction of labor (IOL), 31 in the diet only, and 34 in the diet with medication group. 6 babies weighed 4 kg or more at birth (4 in the diet only and 2 in the diet with medication group). 

Conclusion: Most of the patients were overweight to obese, however, a good percentage were controlled by diet without medications, achieved longer pregnancies, and had less IOLs. We recommend to inforce diet control and multidisciplinary care, to help reduce medicalization and intervention in GDM patients. 

 

 
Categories (required)
 
High Risk Pregnancy
 
Authors and Affiliations (required)
 
Dr SHAHAD Mahmoud Hussein (Presenting) smmahmoud@ssmc.ae
Shaikh Shakhbout Medical City, Abu Dhabi, UAE
Khalifa University, Abu Dhabi, UAE
 
Dr Rawaa Ouda dr.rawaaouda@gmail.com
Gulf Medical University, Ajman, UAE
 
Dr Aliaa Maher Al Chaar alchaar.aliaa01@gmail.com
Mediclinic Airport Road Hospital, Abu Dhabi, UAE
 
Dr Hala Marwan Safadi halasafadi01@gmail.com
Gulf Medical University, Ajman, UAE
 
Dr Salman Mohamad Salman salmanmssalman@gmail.com
Gulf Medical University, Ajman, UAE
 
Dr Ibrahim Mohammed 2018m0103@mygmu.ac.ae
Gulf Medical University, Ajman, UAE
 
Dr Iman Gaafar Younis igyounis@ssmc.ae
Shaikh Shakhbout Medical City, Abu Dhabi, UAE
 
Dr Reem Mohamed Mohyeldin rmohyeldin@ssmc.ae
Shaikh Shakhbout Medical City, Abu Dhabi, UAE
 
Dr Dima Ribhi Jarrar djarrar@ssmc.ae
Shaikh Shakhbout Medical City, Abu Dhabi, UAE
 
Dr Saira Aatif Riaz sariaz@ssmc.ae
Shaikh Shakhbout Medical City, Abu Dhabi, UAE
 
 
RCOG World Congress 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.